| Size & multiples | |||
| Market Cap | NOK 505.0M | Enterprise Value | — |
| P/E (TTM) | — | PEG (trailing) | — |
| P/S | — | P/FCF | — |
| EV/EBITDA | — | EV/EBIT | — |
| EV/Sales | — | EV/FCF | — |
| FCF Yield | −4.78% | Buyback Yield | — |
| Owner Earnings (TTM) | -NOK 40.0M | Owner Earnings Yield | −7.91% |
| Shareholder Yield | — | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 2.45 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 16.25% |
| After-tax Cost of Debt | — | WACC | — |
| ROIC | — | EVA Spread (ROIC−WACC) | — |
| EVA | — | ||
FCF runs above owner earnings — under-maintenance or a working-capital release is flattering current cash.
Flows latest annual · EPS TTM -NOK 0.18 · revenue TTM — · FCF TTM -NOK 24.1M (in NOK)
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| FCF Yield | -4.8% | -7.8% | -34.7%–1.4% | 57 ↑strong |
| ROE | -13.9% | -36.8% | -92.5%–4.5% | 65 ↑strong |
